Journal
JOURNAL OF HUNTINGTONS DISEASE
Volume 10, Issue 1, Pages 149-163Publisher
IOS PRESS
DOI: 10.3233/JHD-200423
Keywords
Huntington's disease; Friedreich ataxia; Fragile X-related disorders; FMR1-associated disorders; trinucleotide repeat instability; mismatch repair; base excision repair; double-strand break repair; non-homologous end-joining
Categories
Funding
- Intramural Program of the National Institute of Diabetes, Kidney and Digestive Diseases
- Huntington's Disease Society of America
Ask authors/readers for more resources
Huntington's disease is caused by expanded DNA repeats, specifically a CAG trinucleotide located in the huntingtin gene, resulting in neuronal cell death. Somatic CAG expansion in the brain may contribute to earlier disease onset and increased severity in individuals. Additional genetic factors and pathways may modify somatic expansion, providing potential druggable targets for diseases like HD.
Huntington's disease (HD) is one of a large group of human disorders that are caused by expanded DNA repeats. These repeat expansion disorders can have repeat units of different size and sequence that can be located in any part of the gene and, while the pathological consequences of the expansion can differ widely, there is evidence to suggest that the underlying mutational mechanism may be similar. In the case of HD, the expanded repeat unit is a CAG trinucleotide located in exon 1 of the huntingtin (HTT) gene, resulting in an expanded polyglutamine tract in the huntingtin protein. Expansion results in neuronal cell death, particularly in the striatum. Emerging evidence suggests that somatic CAG expansion, specifically expansion occurring in the brain during the lifetime of an individual, contributes to an earlier disease onset and increased severity. In this review we will discuss mouse models of two non-CAG repeat expansion diseases, specifically the Fragile X-related disorders (FXDs) and Friedreich ataxia (FRDA). We will compare and contrast these models with mouse and patient-derived cell models of various other repeat expansion disorders and the relevance of these findings for somatic expansion in HD. We will also describe additional genetic factors and pathways that modify somatic expansion in the FXD mouse model for which no comparable data yet exists in HD mice or humans. These additional factors expand the potential druggable space for diseases like HD where somatic expansion is a significant contributor to disease impact.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available